India Operations

Market standing

Ranked 15th in the Indian pharmaceutical industry MAT August, 2023 (source: Awacs). Leader by Rx in Diabetes & Cardiology segments. We are the leaders in the oral anti-diabetic segment in India in terms of both prescriptions and value. It is a position we have held consistently for almost two decades. In 2022-23, we crossed the milestone of Rs. 4,000 Crs.

We are also leaders in the cardiovascular disease segment in terms of prescription generation. In terms of value, we rank fourth.

  • Diabetes
  • Cardiovascular
  • Vitamins / Nutritional / Minerals
  • Dermatology/Cosmetology
  • Gynaecology

Presence in Nutritional and Gynaecology segments through innovative products from partners in USA and Europe and in Cosmetology with a leading European brand.

© 2024 USV Private Limited. All Rights Reserved.